Clinical Analysis of Intracranial Hemangiopericytoma.
10.3340/jkns.2013.54.4.309
- Author:
Byoung Joo PARK
1
;
Young Il KIM
;
Yong Kil HONG
;
Sin Soo JEUN
;
Kwan Sung LEE
;
Youn Soo LEE
Author Information
1. Department of Neurosurgery, College of Medicine, The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, Korea. medi0204@gmail.com
- Publication Type:Original Article
- Keywords:
Hemangiopericytoma;
Intracranial;
Radiotherapy;
Surgery;
Adjuvant;
Recurrence
- MeSH:
Diagnosis;
Drug Therapy;
Follow-Up Studies;
General Surgery;
Hemangiopericytoma*;
Humans;
Male;
Meningioma;
Mortality;
Neoplasm Metastasis;
Radiotherapy;
Radiotherapy, Adjuvant;
Recurrence;
Retrospective Studies;
Survival Rate
- From:Journal of Korean Neurosurgical Society
2013;54(4):309-316
- CountryRepublic of Korea
- Language:English
-
Abstract:
OBJECTIVE: Intracranial hemangiopericytomas (HPCs) are rare tumors with aggressive behavior, including local recurrence and distant metastasis. We conducted this retrospective study to evaluate the efficacy of grossly total resection and adjuvant radiotherapy (RT) for these tumors. METHODS: A total of 13 patients treated for intracranial HPC from January 1995 through May 2013 were included in this retrospective study. We analyzed the clinical presentations, radiologic appearances, treatment results, and follow-up outcomes, as well as reviewed other studies. RESULTS: The ages of the patients at the time of diagnosis ranged from 26 to 73 years (mean : 48 years). The majority of the patients were male (92.3%), and the majority of the tumors were located in the parasagittal and falx. The ratio of intracranial HPCs to meningiomas was 13 : 598 in same period, or 2.2%. Seven patients (53.8%) had anaplastic HPCs. Nine patients (69.2%) underwent gross total tumor resection in the first operation without mortality. Eleven patients (84.6%) underwent postoperative adjuvant RT. Follow-up period ranged from 13 to 185 months (mean : 54.3 months). The local recurrence rate was 46.2% (6/13), and there were no distant metastases. The 10-year survival rate after initial surgery was 83.9%. The initial mean Karnofsky performance scale (KPS) was 70.8 and the final mean KPS was 64.6. CONCLUSION: Gross total tumor resection upon initial surgery is very important. We believe that adjuvant RT is helpful even with maximal tumor resection. Molecular biologic analyses and chemotherapy studies are required to achieve better outcomes in recurrent intracranial HPCs.
